Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 82-4973519

THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES

Tax-exempt · PORTLAND, OR 97212

Financials

$109K$78K2023$133K$94K2024$79K$42K2025
Revenue Expenses · by fiscal year end
Financials of THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$79,476$41,506$37,970$127,286$0$127,286
December 31, 2024990$132,537$94,312$38,225$97,016$7,700$89,316
December 31, 2023990$109,326$77,556$31,770$61,781$12,000$49,781
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$68,152
Membership dues
$227
Program service revenue
$11,959
Investment income
-$635
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$0
Other salaries and wages
$2,813
Salaries, compensation and benefits (total)
$4,103
Professional fundraising fees
$0
Program services (functional)
$34,953
Management and general (functional)
$6,404
Fundraising (functional)
$149

Balance sheet and other

Total assets, start of year
$97,016
Total assets, end of year
$127,286
Total liabilities, end of year
$0
Net assets, end of year
$127,286
Net assets without donor restrictions
$127,286
Gross receipts
$79,476
Employees
1
Year formed
2018
State of legal domicile
OR

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
Bernard SilvernailPresident, Director
Trustee or director, Officer
30$0
Richard BaileyTreasurer, Director
Trustee or director, Officer
1$0
Cathal CadogonDirector
Trustee or director
1$0
Christopher BlazesDirector
Trustee or director
1$0
Judd KatzDirector
Trustee or director
1$0
Alexis RitvoMedical Director
Trustee or director
2$0
Jaden BrandtDirector
Trustee or director
4$0
990 for the year ended December 31, 2024: 9 people
NameTitleHours / weekCompensation
Bernard SilvernailPresident, Director
Trustee or director, Officer
40$0
Richard BaileyTreasurer, Director
Trustee or director, Officer
1$0
Lori MorDirector
Trustee or director
1$0
Cathal CadogonDirector
Trustee or director
1$0
Christopher BlazesDirector
Trustee or director
1$0
Jolene BressiDirector
Trustee or director
4$0
Judd KatzDirector
Trustee or director
1$0
Alexis RitvoMedical Director
Trustee or director
3$0
Jaden BrandtDirector
Trustee or director
4$0
990 for the year ended December 31, 2023: 9 people
NameTitleHours / weekCompensation
Alexis RitvoMedical Director
Trustee or director
3$24,000
Bernard SilvernailPresident, Director
Trustee or director, Officer
40$0
Richard BaileyTreasurer, Director
Trustee or director, Officer
1$0
Lori MorDirector
Trustee or director
1$0
Cathal CadogonDirector
Trustee or director
1$0
Christopher BlazesDirector
Trustee or director
1$0
Jolene BressiDirector
Trustee or director
4$0
Judd KatzDirector
Trustee or director
1$0
Jaden BrandtDirector
Trustee or director
4$0

Address and contacts

Address (IRS master file)
3221 NE 30TH AVE, PORTLAND, OR 97212-2610
In care of
% BERNARD SILVERNAIL
Principal officer (990 for 2025)
Bernard Silvernail, 8028 E Maguey Dr, Tucson, AZ 85750
Signed the 990
Bernard Silvernail, President
Phone
(503) 704-8983

Mission

Our mission is to reduce the harm caused by benzodiazepines and Z-drugs by making evidence-based improvements to the prescribing of these medications.

990 for the year ended December 31, 2025

Program accomplishments

  • Wrote 3 medical articles on benzodiazepines and published them in peer-reviewed medical journals.
    Expenses $12,983
  • Formed a multi-state coalition of medical experts, wrote and submitted a grant proposal for a randomized controlled medical study
    Expenses $16,111
  • Analyzed and supported a randomized controlled study.
    Expenses $5,859 · revenue $11,959

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

File the 2026 990-EZ for THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES

Due May 17, 2027 · e-filed with the IRS by 990.tax, an IRS-authorized e-file provider

IRS record

EIN
82-4973519
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2020
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H05)
Assets (IRS master file)
$127,286
Income (IRS master file)
$79,476

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$79,476$41,506$127,286IRS
990December 2024$132,537$94,312$97,016IRS
990December 2023$109,326$77,556$61,781XML
990-PFDecember 2020–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 82-4973519).

Questions about THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES

What is the EIN of THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES?
The employer identification number (EIN) of THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES is 82-4973519.
Is THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2020.
Are donations to THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES?
The 990 for the year ended December 31, 2025 names Bernard Silvernail.
Who are the officers and directors of THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES?
The 990 for the year ended December 31, 2025 lists 7 people; 0 received compensation from the organization.
How much revenue does THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES have?
On its 990 for the year ended December 31, 2025 it reported revenue of $79,476, expenses of $41,506 and total assets of $127,286 at year end.

Other nonprofits in PORTLAND

All nonprofits in PORTLAND · Oregon · Medical research